Estrogen and progesterone induce persistent increases in p53-dependent apoptosis and suppress mammary tumors in BALB/c-Trp53+/- mice
2008

Estrogen and Progesterone Increase Apoptosis and Suppress Mammary Tumors in Mice

Sample size: 96 publication 10 minutes Evidence: moderate

Author Information

Author(s): Dunphy Karen A, Blackburn Anneke C, Yan Haoheng, O'Connell Lauren R, Jerry D Joseph

Primary Institution: University of Massachusetts

Hypothesis

Does treatment with estrogen and progesterone enhance p53 responsiveness to DNA damage and confer resistance to mammary tumors in a mouse model?

Conclusion

Estrogen and progesterone treatment increases p53-mediated apoptosis in mammary epithelium and reduces tumor incidence, but this effect is not retained in transplanted epithelial cells.

Supporting Evidence

  • Estrogen and progesterone treatment increased p53 accumulation in mammary tissues.
  • Apoptotic responses to radiation were significantly higher in hormone-treated mice compared to controls.
  • Parity delayed the appearance of spontaneous mammary tumors in BALB/c-Trp53+/- mice.

Takeaway

Giving female mice hormones like estrogen and progesterone helps their bodies fight off breast cancer by making their cells better at killing damaged ones.

Methodology

Mice with different p53 statuses were treated with estrogen and progesterone for 14 days, then tested for responses to radiation and tumor incidence.

Potential Biases

Potential bias in the selection of mouse models and hormonal treatment protocols.

Limitations

The study's findings may not be directly applicable to humans due to species differences.

Participant Demographics

BALB/c-Trp53+/- mice, including both parous and nulliparous females.

Statistical Information

P-Value

p<0.05

Statistical Significance

p<0.05

Digital Object Identifier (DOI)

10.1186/bcr2094

Want to read the original?

Access the complete publication on the publisher's website

View Original Publication